These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9090310

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacological properties of beta 3-adrenoceptors.
    Nisoli E, Carruba MO.
    Trends Pharmacol Sci; 1997 Jul; 18(7):257-8. PubMed ID: 9253858
    [No Abstract] [Full Text] [Related]

  • 3. [Beta 3-receptors: incidence and properties, possible clinical significance].
    Gullestad L, Osnes JB.
    Tidsskr Nor Laegeforen; 1995 Jan 10; 115(1):45-9. PubMed ID: 7846660
    [Abstract] [Full Text] [Related]

  • 4. Beta 3-adrenoceptors and intestinal motility.
    Manara L, Croci T, Landi M.
    Fundam Clin Pharmacol; 1995 Jan 10; 9(4):332-42. PubMed ID: 8566932
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.
    Konkar AA, Zhai Y, Granneman JG.
    Mol Pharmacol; 2000 Feb 10; 57(2):252-8. PubMed ID: 10648634
    [Abstract] [Full Text] [Related]

  • 7. In vitro selectivity of agonists and antagonists for beta 1- and beta 2-adrenoceptor subtypes in rat brain.
    Beer M, Richardson A, Poat J, Iversen LL, Stahl SM.
    Biochem Pharmacol; 1988 Mar 15; 37(6):1145-51. PubMed ID: 2895652
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.
    Ruffolo RR, Bondinell W, Hieble JP.
    J Med Chem; 1995 Sep 15; 38(19):3681-716. PubMed ID: 7562902
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.
    Weiland GA, Minneman KP, Molinoff PB.
    Mol Pharmacol; 1980 Nov 15; 18(3):341-7. PubMed ID: 6110167
    [No Abstract] [Full Text] [Related]

  • 13. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C, Galitzky J, Fontana E, Atgié C, Lafontan M, Berlan M.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr 15; 359(4):310-21. PubMed ID: 10344530
    [Abstract] [Full Text] [Related]

  • 14. Experimental studies with selective beta-adrenergic agonists and antagonists in animals.
    Stock MJ.
    Int J Obes Relat Metab Disord; 1993 Dec 15; 17 Suppl 3():S69-72; discussion S82. PubMed ID: 7907258
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.
    Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb 15; 369(2):151-9. PubMed ID: 14730417
    [Abstract] [Full Text] [Related]

  • 19. Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.
    Blin N, Nahmias C, Drumare MF, Strosberg AD.
    Br J Pharmacol; 1994 Jul 15; 112(3):911-9. PubMed ID: 7921620
    [Abstract] [Full Text] [Related]

  • 20. LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
    Louis SN, Nero TL, Iakovidis D, Jackman GP, Louis WJ.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):431-5. PubMed ID: 10079020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.